FLGT News and Press, Fulgent Genetics Inc. From 10/16/25

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its third quarter 2025 financial results bef...

2025-09-11 19:00:00 ET Explore the exciting world of Fulgent Genetics (NASDAQ: FLGT) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities! *Stoc...

2025-09-08 13:58:00 ET ... Read the full article on Seeking Alpha For further details see: Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

2025-08-28 16:15:00 ET Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on through generations. So what is genetics investing? When it comes to genetics investing, companies in this niche of the life science sect...

2025-08-01 16:26:08 ET Friday's stock market was generally a gloomy place, but apparently someone forgot to tell Fulgent Genetics (NASDAQ: FLGT) . The company's shares were soaring in late-session action, with a very healthy rise of more than 8%. At that point, the bellwether S&am...

2025-08-01 12:29:17 ET More on Fulgent Genetics Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript Fulgent Genetics, Inc. 2025 Q2 - Results - Earnings Call Presentation Fulgent Genetics: A 'Sum Of The Parts' Story Fulgent Genetics Q2 2025 Earnings...

2025-08-01 12:28:09 ET Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Conference Call August 01 2025, 08:30 AM ET Company Participants Brandon Perthuis - Chief Commercial Officer Ming Hsieh - Chairman & CEO Paul Kim - Chief Financial Officer Conference ...

2025-08-01 07:01:39 ET More on Fulgent Genetics Fulgent Genetics: A 'Sum Of The Parts' Story Fulgent Genetics Q2 2025 Earnings Preview Seeking Alpha’s Quant Rating on Fulgent Genetics Historical earnings data for Fulgent Genetics Financial info...

Linde plc (LIN) is expected to report $4.03 for Q2 2025 CNH Industrial N.V. (CNH) is expected to report $0.16 for Q2 2025 Piper Sandler Companies (PIPR) is expected to report $1.99 for Q2 2025 EchoStar Corporation (SATS) is expected to report $-1.12 for Q2 2025 LyondellBasell Indu...

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of $36.2 million, or Non-GAAP gross margin of 44.2% GAAP loss of $19.0 million, ...